Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 890

2.
3.

Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.

Davoren A, Dillon AD, Power JP, Donnellan J, Quinn JM, Willis JW, Lawlor EM, O'Riordan JM.

Transfusion. 2002 Nov;42(11):1501-6.

PMID:
12421225
4.

[Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months].

Durand F, Danic B, Tardivel R, Semana G, Gouezec H, Martinot M, Marcellin P, Beauplet A.

Transfus Clin Biol. 2000 Jun;7(3):242-50. French.

PMID:
10919211
5.

Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors.

Tobler LH, Stramer SL, Lee SR, Baggett D, Wright D, Hirschkorn D, Walsh I, Busch MP.

Vox Sang. 2005 Nov;89(4):201-7.

PMID:
16262752
6.

Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.

Busch MP, Glynn SA, Stramer SL, Orland J, Murphy EL, Wright DJ, Kleinman S; NHLBI Retrovirus Epidemiology Donor Study (REDS) Group.

Transfusion. 2006 Mar;46(3):469-75.

PMID:
16533292
7.

A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.

Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ.

Transfusion. 2008 Jun;48(6):1198-206. doi: 10.1111/j.1537-2995.2008.01672.x. Epub 2008 Apr 14.

PMID:
18422856
8.

Acute nosocomial HCV infection detected by NAT of a regular blood donor.

Larke B, Hu YW, Krajden M, Scalia V, Byrne SK, Boychuk LR, Klein J.

Transfusion. 2002 Jun;42(6):759-65.

PMID:
12147030
9.

Dynamics of viremia in early hepatitis C virus infection.

Glynn SA, Wright DJ, Kleinman SH, Hirschkorn D, Tu Y, Heldebrant C, Smith R, Giachetti C, Gallarda J, Busch MP.

Transfusion. 2005 Jun;45(6):994-1002.

PMID:
15934999
11.

Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase' blood donations.

Lee SR, Peterson J, Niven P, Bahl C, Page E, DeLeys R, Giordano-Schmidt D, Baggett D, Green G.

Vox Sang. 2001 Jan;80(1):19-23.

PMID:
11339063
13.

Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.

O'Riordan JM, Conroy A, Nourse C, Yap PL, McDonald GS, Kaminski G, Leong K, Lawlor E, Davoren A, Strong K, Davidson F, Lloyd A, Power J.

Transfus Med. 1998 Dec;8(4):303-8.

PMID:
9881424
14.

Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.

Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE.

Transfusion. 2007 Oct;47(10):1803-8.

PMID:
17880604
15.

Antibodies to a novel antigen in acute hepatitis C virus infections.

Tobler LH, Stramer SL, Chien DY, Lin S, Arcangel P, Phelps BH, Cooper SL, Busch MP.

Vox Sang. 2007 Jan;92(1):1-7.

PMID:
17181584
16.

Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.

Weusten JJ, van Drimmelen HA, Lelie PN.

Transfusion. 2002 May;42(5):537-48.

PMID:
12084161
17.

Follow-up study of anti-hepatitis C virus antibodies in blood donors implicated in post-transfusion non-A, non-B hepatitis.

Mazda T, Nakata K, Bannai M, Miyamura T, Chiba J, Ohba H, Kaminuma Y, Katayama T.

Transfus Med. 1993 Jun;3(2):149-51.

PMID:
7690640
18.

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.

Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.

Transfusion. 2009 Jun;49(6):1115-25. doi: 10.1111/j.1537-2995.2009.02110.x. Epub 2009 Feb 27.

PMID:
19309474
19.

Safety of blood supply in the Caribbean countries: role of screening blood donors for markers of hepatitis B and C viruses.

Cruz JR, Pérez-Rosales MD, Zicker F, Schmunis GA.

J Clin Virol. 2005 Dec;34 Suppl 2:S75-80.

PMID:
16461244
20.

Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.

Nübling CM, Chudy M, Volkers P, Löwer J.

Transfusion. 2006 Nov;46(11):1886-91.

PMID:
17076842
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk